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A Reproductive Hazards Research Agenda for
the 1990s
by Michele Marcus,1 Ellen Silbergeld,2 Donald
Mattison,3 and the Research Needs Working Group4
There is substantial scientific and public concern about the potential effects ofoccupational and environ-
mental toxicants on reproductive health. These effects include impaired functioning of the reproductive
systems of men and women as well as a broad spectrum of developmental problems expressed in offspring.
Research on reproduction and development is amongthe most complex undertakings in biomedical research.
This complexity is due in part to the intricate biology of reproduction, the multiple targets involved (male,
female, and offspring), the uncertainties in extrapolating from animal models to humans, and the problems
involved in accurately characterizing exposures and outcomes in epidemiologic investigations. However, given
the relatively brief history of research into toxicant-induced reproductive health effects, we have made
enormous strides in ourknowledgeoverthepastdecade. Inparticular, recentadvances inreproductivebiology
and biotechnology and in the development of biological markers of exposure, effect, and susceptibility are
greatly enhancing our ability to study cause-effect relationships. In this paper, the Research Needs Working
Groupproposes waystoapplyexistingknowledge tobetterprotectreproductivehealthandsuggestsdirections
forfuture research. Fulfilling this challengingagendawillrequire responsiblecooperation bylabor, industry,
government, individual citizens, and the scientific community. Further research and collaboration are
essential tobothpreventadversereproductive anddevelopmental outcomesandtoformulateasoundscientific
basis for policy making.
Introduction
Reproductive health policy decisions should protect our
reproductive health, civil rights, and economic oppor-
tunities. Exposures to men and women in the workplace
and the general environment are of concern. Policy deci-
sions should be guided by a clear knowledge ofthe factors
that can result in reproductive harm as well as those that
pose little or no risk. Unfortunately, in the area of
reproductive risk, the scientific knowledge needed to pro-
vide clear guidance to policymakers in the public or the
private sector is frequently lacking.
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The purpose ofthis paper is to summarize some ofthe
difficultiesinvolvedinassessingreproductiveand develop-
mental risk potentially associated with exposure to toxi-
cants in the workplace or environment. We also describe
some promising new developments in the assessment of
reproductive hazards. The paper concludes with policy
recommendations and a research agenda agreed upon by
participants in the Research NeedsWorkingGroup atthe
Woods Hole Conference.
Scope of the Problem
Environmental hazards to reproduction and develop-
ment are a source of substantial scientific and public
concern. Inthe1960s,theuseofthalidomideinEuropeand
environmental contamination bymethyl mercuryin Japan
madethepossibilityofbirthdefectsfromdrugandchemi-
cal exposure tragically apparent. Early in the 1970s,
diethylstilbestrol was recognized as causing adenocar-
cinoma ofthe vagina in youngwomen whose mothers had
takenthedrugduringpregnancy (1). Laterinthatdecade,
it was discovered that men occupationally exposed to the
nematocide dibromochloropropane (DBCP) were subject
to varying degrees of testicular toxicity culminating, in
someinstances,ininfertility(2).Theseandotherexamples
of adverse effects on reproduction, coupled with anMARCUS ET AL.
increase in the number of couples seeking treatment for
infertility (due primarily to delayed childearing) and an
increase in the number ofwomen in the workforce during
their childbearing years, have intensified public concern.
In considering reproductive and developmental toxicity,
we include impairment in the functioning ofthe reproduc-
tive system ofmales and females (which maybe evidenced
by the inability to reproduce) as well as toxic effects
expressed inthe offspring. Environmental agents mayact
at several stages during reproduction and development
which include complex, interdependent processes involv-
ing the nervous, endocrine, and immune systems.
The extent of reproductive dysfunction and adverse
pregnancy outcomes in the United States is significant.
According to currently available data, 1 in 12 couples of
reproductive age is infertile, that is, they are unable to
produce a viable pregnancy during 1 year ofunprotected
intercourse (3). Ten to twentypercent ofrecognized preg-
nancies end in pregnancy loss and at least as many
conceptuses arelostpriorto recognition ofthepregnancy
(4). Low birth weight, a major contributor to perinatal
morbidity and mortality, affects approximately 7% of all
newborns and more than 13% ofblack infants (5). Two to
three percent of liveborns have major congenital malfor-
mations recognized at birth. More have malformations
diagnosed as theygrowolder (6). Itis not clearhowmany
children suffer from developmental delay or other func-
tional deficits. Otherproblems ofthe reproductive system
thataffectindividuals ofeithersexinclude sexualdysfunc-
tion, hormonalimbalances, and alterations inreproductive
maturityorsenescence. Systematicdataontheprevalence
ofthese end points are lacking.
The extent to which environmental and occupational
exposures to men and women contribute to the burden of
reproductive and developmental dysfunction is unknown.
Only asmallproportion ofthe morethan 60,000chemicals
in commerce today have been adequately tested for
reproductive ordevelopmentaltoxicity. Notonlyarechem-
ical agents of concern, but biological and physical agents
as well as psychological stress are capable ofinterfering
with reproductive processes. Only ahandful ofagents are
generally recognized human reproductive toxicants. This
small number reflects, in part, the difficulties ofidentify-
ing causal associations in humans as well as the lack of
data.
Research Advances and Limitations
Research on reproduction and development is among
the most complex undertakings in biomedical research.
This complexity is due in part to the fact that more than
one organism is involved in many aspects ofreproduction
(the male and female) and development (both parents and
the offspring). In addition, most current knowledge about
reproductivetoxicityderivesfrom studies ofexperimental
animals whose anatomy, physiology, and metabolism of
xenobiotic agents may differ from those ofhumans. Since
animal studies must continue to play a critical role in
reproductive toxicity testing, more information is needed
onthe predictivevalue ofanimal experiments for humans.
Recent advances in reproductive biology and bio-
technology (exemplified by in vitro fertilization) have
increased opportunities for the study of a wide range of
reproductive end points, including subtle effects of expo-
sure to environmental toxicants. Biological markers for
assessing very early pregnancy loss, endocrine function,
reproductive senescence, male reproductive capacity, and
genetic susceptibility have been developed and are begin-
ning to be used in epidemiologic studies ofenvironmental
exposures (7).Thesesensitive newtoolspromisetogreatly
enhance our ability to study cause-effect relationships in
reproductive epidemiology.
Valid results in the epidemiologic study ofreproductive
and developmental risks depend on ourabilitytoprecisely
ascertain exposure and outcome. Unlike the development
of chronic diseases, where total duration of exposure is
typicallythe mostrelevant exposure parameter, effects on
reproduction and development are often the result of
short-term exposures during critical periods of vul-
nerability. Fetal organogenesis, which occurs primarily
duringthefirsttrimesterofpregnancy,is one suchvulner-
able period. Ovulation and spermatogenesis are others.
In some cases, the result of a toxic exposure may not
become evidentuntilyearslater. This can occurby atleast
three distinct mechanisms. First, some toxicants bioac-
cumulate in parental tissues and may be released during
pregnancy, lactation, or spermatogenesis. For example,
polychlorinated biphenyls (PCBs) are stored in adipose
tissue and lead is stored inbone. These compounds canbe
released fromparental tissues manyyears afterexposure
hasoccurred. Second,toxicantsthatdepletethenumberof
female germ cells may result in a shortened reproductive
life span,whichwould notbeevidentuntil senescence. For
example, it has been shown in rodents that polycyclic
aromatic hydrocarbons (PAH), components of cigarette
smoke, can be lethal to oocytes (8). This may explain the
earlier menopause observed in women who smoke ciga-
rettes (9). Finally, toxic effects to offspring may not
become apparent until a particular stage in postnatal
development. For example, neurobehavioral or carcino-
genic end points in developing offspring can follow mater-
nal or paternal preconceptional exposure.
One of the most diffiecult tasks in reproductive epi-
demiology is accurately assessing exposure. Frequently,
occupational studies must rely on job titles to impute
exposures. Misclassiflcation of exposure by this method
can be substantial (10). The samejob title may be associ-
atedwith vastly differentjob tasks or exposures in differ-
ent companies or locations. The impact of using an
inaccurate measure of exposure (if unbiased) is toward
obscuring a true effect. Improvements in industrial
hygiene assessments ofoccupational exposure, as well as
the development ofbiological markers of exposure, show
great promise for improving our ability to quantify expo-
sure in biologically relevant tissues.
Ascertainment of outcome in the study ofreproductive
and developmental risksis alsoproblematic. Definitions of
spontaneous abortion, congenital malformations, semen
abnormalities, and developmental delay are not consis-
tently applied in clinical practice. National surveillance
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data are not available for any ofthese outcomes. Patterns
ofaccess and utilization ofhealth care services also affect
the reporting of adverse reproductive or developmental
outcomes. Forexample, manyearlyspontaneous abortions
remain undetected, since women do not seek clinical ser-
vices for these outcomes. Manypeople with fertility prob-
lems may not seek medical intervention due to lack of
adequate health care coverage.
In spite ofthese difficulties, it is in the area ofoutcome
assessment that the greatest strides have been made in
recent years. For example, it is now possible to study the
DNA in fetal cells and in sperm, evaluate aspects of
endocrine function with spot urine samples, detect preg-
nancy around the time ofimplantation (about aweek after
fertilization), and detect subtle neurodevelopmental dys-
function.
However, theclinicalrelevance ofsubtlechanges (e.g.,in
neurobehavioral, semen, or endocrine parameters) still
needs to be determined.
Individual biological responses to a toxicant may be
modified by demographic, nutritional, or genetic factors,
as well as by health status and concomitant exposures.
Deficiencies of iron, zinc, and calcium, for example, are
associatedwithincreasedgastrointestinalleadabsorption
(11). The principle of genetic variability in response to
xenobiotic exposure is well established, and evidence is
accumulating to suggest genetic influences on teratogenic
outcomes. For example, recent evidence suggests that the
risk for alcohol-related birth defects may be affected by
genetic polymorphisms of alcohol dehydrogenase, the
rate-limiting enzyme in alcohol metabolism (12). Beyond
these data,verylittle is known aboutvariations in suscep-
tibilitytoreproductive ordevelopmental toxicants orabout
synergistic effects ofmultiple exposures.
Scientific research into the reproductive and develop-
mental effects of occupational and environmental chemi-
cals started relatively recently. Given its shorthistory, the
advances that have been made in the field are impressive.
However, we still have much to learn about reproductive
and developmental hazards andneedimproved methodsto
identify potential toxicants. In the meantime and despite
our best efforts, cases will continue to arise where the
current science of reproductive hazards is simply inade-
quate to meet the more immediate needs ofpolicymakers
or concerned workers and citizens. Given the many years
of study required to suggest cause-effect relationships,
scientists will most frequently not have clear-cut answers
to the questions asked by these sectors. Understanding
the limitations of the currently-available scientific evi-
dence,whilecontinuallytryingtoimproveuponthem,is an
essential part of the job of scientists, policymakers, and
concerned individuals ifwe are to derive maximum benefit
fromresearch on reproductive and developmental toxicants.
Recommendations
Policy Recommendations
The critical scientific evaluation of reproductive and
developmental toxicity data should be undertaken on an
ongoing basis by a suitable national or international
agency. This agency should determine which agents
require immediate action and prioritize agents requiring
furtherresearch.Agentsforwhichthere are dataregard-
ing exposure of one sex only should be placed on the
priority list for research on the other sex. This measure
will help avoid discriminatorypoliciesthatcan resultfrom
unequal data ratherthan unequal effects. Input should be
sought from labor unions, community groups, and com-
panies regarding the identification ofagents or exposures
that are of concern. These scientific evaluations should
take into account: a) the quality of the data including
experimental design, statistical power, and measurement
of exposure and outcomes. These considerations apply to
human, animal, and in vitro studies; b) for nonhuman
studies, the validity of extrapolation to humans. Consid-
eration shouldbegiventoknowledge ofpharmacokinetics,
site ofaction, and mechanism; c) the potency ofthe agent
orthemagnitude oftheeffect; d)theendpoint(s) affected;
and e) the number of humans likely to be exposed. The
evaluation given agents subject to Proposition 65 regula-
tion in California should serve as a starting point for the
development of an evaluation methodology (13-15).
A testing strategy should be developed to evaluate
agents for reproductive and developmental toxicity before
introduction into the workplace and general environment.
Since the number ofagents currently in use is quite large
(greaterthan 60,000bysome estimates), agentsin current
use shouldbe prioritized fortesting. Criteria forprioritiz-
ation should include the number of humans likely to be
exposed, the likelihood that the agent is toxic (such as
structural similarity to a known toxic agent), and its
persistence oraccumulation. Indevelopingatesting strat-
egy, the full range oftestingtechniques should be consid-
ered including computer analysis of structure-activity
relationships, short-term in vitro assays, in vivo animal
bioassays, and human epidemiologic studies.
While there are many gaps in our knowledge of
reproductive and developmental risk, sufficient data cur-
rentlyexistto classify anumber ofagents as reproductive
or developmental toxicants. Several lists of reproductive
and developmental toxicants havebeen developed [e.g., the
recentreportonregulation ofreproductive hazardsbythe
General Accounting Office (16)]. This information should
be acted upon immediately. Examples of actions to be
takeninclude source reduction, regulatoryactivity, and/or
risk communication.
The voluntary participation of companies, unions, and
individuals is necessary for the conduct of human epi-
demiologic studies and should be encouraged. Policies
should be formulated to encourage companies, unions, and
industries to conduct and to participate in reproductive
health research (both animal and human). It is also neces-
sary to develop policies that will encourage individuals to
participate in epidemiologic research. Low participation
rates can seriously compromise the validity of epi-
demiologic research. Low participation rates are often a
probleminstudiesrequiringsamplingofbodilyfluids such
as semen,blood, orurine. However, these studies showthe
greatestpromisetoelucidateexposure-effectrelationships
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because of their more precise measurement of exposure
and/or health outcome. We therefore make the following
recommendations to enhanceparticipation inreproductive
hazards research.
Researchers should adequately communicate study
results to individuals, unions, and companies. It is very
importantforstudysubjectsnottofeelasiftheyhavebeen
used and discarded. Funds for notification should be built
into the budget of all epidemiologic studies. Individuals
should receive written notification ofany test results that
are clinically relevant as well as an explanation and inter-
pretation ofanyunique ornonstandardteststhatmightbe
clinically relevant. This may include biological markers of
subclinical effects. Individuals, companies, and unions
should receive, in language they can understand, a sum-
mary ofthe overall results ofthe study.
Individuals, unions, and companies should be informed
of the logistics of a research study and the goals of the
studybefore itbegins.Attempts should bemadetoinvolve
them in the design of epidemiologic studies and the dis-
semination of results. Involvement in the design stage is
appropriate onlywhen it will not compromise the validity
ofthestudy. Individualparticipantsshouldremainblindto
specific study hypotheses only if this knowledge poten-
tially affects their responses or the information gathered
on them. Examples of involvement during the planning
stages may include identification ofhealth endpoints sus-
pected to be in excess, designation ofagents suspected to
be toxic, identification ofjobs withthe greatest exposures,
descriptions of work practices, and determination of
appropriate means ofcommunicating to employees or the
community.
Investigators should disclose the source(s) of funding
for research. Steps must be taken to ensure the confiden-
tiality of data. Individual identifiable data should be pro-
tected from any form of disclosure including subpeona.
Research on the factors that influence participation in
epidemiologic studies should be encouraged. Attention
should be directed to including neglected groups such as
African Americans and Latino Americans in appropriate
studies.
Teratogen Information Services should be encouraged
to use a standardized reporting form and software to
record exposure, gestational age atexposure (orpregesta-
tional time ofexposure), outcome ofpregnancy, and demo-
graphic information so that their experience can be more
useful as research data. Data generated from these uni-
form reports should be collected, summarized, and pub-
lished in hard copy and on diskette at regular intervals.
This data might be used in the following ways: a) to
generate hypotheses (i.e., sentinel health events and case
series), b) to contribute to prioritizing agents forresearch
(compounds or agents that generate the most inquiries),
and c) to testhypotheses withprospectivelycollected data
onindividualswho callTeratogenInformation Services. In
particular, it may be possible to compare pregnancy out-
come among women exposed to a particular substance
with pregnancy outcome amongwomenwhowere exposed
to an innocuous substance. Nearly complete follow-up is
essential as well as the control of potential confounders
and the characterization of the population of individuals
who use Teratogen Information Services.
Research Needs
There is a need for population-based data on reproduc-
tiveand developmental endpoints. These datawill allowus
to determine the normal range and variability of these
parameters. It will also allow us to examine geographic
variation and secular trends. Such data are useful for
surveillance, hypothesis generation, and hypothesis test-
ing. Measurement of many of these parameters can be
incorporated into existing periodic national surveys such
astheNationalHealthandNutrition Examination Survey.
Population-based data are needed on such endpoints as
sexual behavior, semen characteristics, serum and urine
endocrine parameters, sexualfunctioning, time to concep-
tion, and reproductive maturity and senescence.
Thereis aneedfornational statistics on suchpregnancy
outcomes as spontaneous abortion, congenital malforma-
tions, and birthweight. These data are necessary for sur-
veillance as well as for hypothesis testing. This
information couldbecompiled through anationaltemplate
for birth certificates and registration of other pregnancy
outcomes. Currently, each state has its own birth certifi-
cate andmanydo notrequirethereportingofspontaneous
abortions. Definitions of stillbirth, spontaneous abortion,
and congenital malformations also vary. A common uni-
form dataset should be established. Birth certificates
shouldinclude aminimum setofinformationincludinglast
menstrual period; complications of pregnancy, labor and
delivery; birthweight; Apgar scores; and congenital mal-
formations. In addition, residential, occupational, demo-
graphic, and smoking information should be collected on
themotherandthefather.Spontaneousabortionsandfetal
deaths should be registered in the same fashion as live-
births regardless ofgestational age at termination ofthe
pregnancy. (Currently, most states require reportingonly
of terminations beyond 20 weeks). In addition, a mecha-
nism should be developed whereby investigators can
secure permission (after human subjects review) to con-
tactindividualsidentifiedthroughvitalrecordsforfurther
study. The state of Washington currently has such a
mechanism in place.
There is a need for better occupational exposure data.
Environments with multiple exposures are particularly
difficult to assess. Major industries should be surveyed
regularly to characterize actual exposures. This survey
should include both questionnaire and industrial hygiene
assessments of exposure. Better techniques need to be
developed to quantify exposures, including further refine-
ment ofbiological markers of exposure. The development
and validation of biological markers of exposure should
take into account issues such as pharmacokinetics and
target organ dose.
There is a need to determine any significant risks of
male-mediated developmental toxicity through both
human epidemiologic studies and experimental animal
studies. This includes an examination ofsuch outcomes as
spontaneous abortion, congenital malformations, low
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birthweight, premature delivery, developmental delay, and
childhood cancer.
There is a need to continue and expand work on the
validation ofthe use ofanimal models in reproductive and
developmental toxicity testing. The predictive value of a
particular test or species may vary by class ofcompound.
There is also a need to develop and to validate short-term
in vitro assays for reproductive and developmental tox-
icity screening. This work will facilitate the evaluation of
the large number of agents currently in use and intro-
duced daily into our lives. These assays should also con-
tribute to the elucidation of structure-activity
relationships.
Techniques used to extrapolate from short-term or
whole-animal toxicity testing to humans must be biolog-
ically based. Such research should include determination
ofpharmacokinetics, site ofaction, and the mechanism of
action. Extrapolation and risk assessment will thereby be
more valid and could include quantitative dose-response
estimates. This information is also necessary to devise
appropriate preventive/intervention strategies.
Functional effects in offspring (e.g., developmental or
behavioral effects) should be included as end points in
studies ofreproductive and developmental toxicity. Func-
tional effects, as well as structural or morphologic effects,
should be included in epidemiologic studies. In addition,
thepredictivevalueoffunctional changesinanimalsneeds
to be further evaluated.
Reproductive health end points other than procreation
should beincluded in studies ofreproductive toxicity. Such
endpoints include menstrual function, endocrine param-
eters, semen parameters, sexual function, and reproduc-
tive maturity and senescence. Physical factors should be
evaluated for reproductive and developmental toxicity.
These factors include temperature, light, noise, vibration,
psychological stress, electromagnetic fields, and ergonom-
ics.
There is a need to determine potential variation in
susceptibilitytotheeffects ofreproductive ordevelopmen-
tal toxicants. Susceptibility may vary with demographic,
nutritional, or genetic factors, aswell as health status and
concomitant exposures. Very little is known about human
susceptibility to reproductive toxicants or about synergis-
tic effects of multiple exposures. Information on suscep-
tibility is important because it has the potential to reduce
the variability in dose-effect relationships (eliminating
"noise"),therebyallowing moreprecisecharacterization of
risk. Understanding those factors that mediate individual
susceptibility may also lead to an understanding of the
mechanism that leads to reproductive harm as well as the
identification of specific components of complex mixtures
that may be toxic. At the same time, it is important that
information on susceptibility not be used to discriminate
against workers or others.
Conclusions
No one should sufferreproductive harm from exposures
at work or in the general environment. However, current
scientific knowledge is often insufficient to predict those
situations which will result in deleterious outcomes. In
cases where adequate knowledge exists, regulatory action
and voluntary control measures by industry should be
implemented.
Responsiblecooperationbylabor,industry,government,
individual citizens, and the scientific community is
required to implement research needed to establish the
scientific basis that will direct future reproductive policy
decisions. Only with this cooperation can we expect to
successfully implement a complex and demanding
research agenda and prevent future reproductive harm.
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